By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that its second-quarter revenues rose 49 percent year over year as sales connected to its flagship technology increased 78 percent.

During the three months ended June 30, the South Easton, Mass.-based sample prep instrument firm posted revenues of $402,104, compared to $270,381 for Q2 2009. Sales of its pressure cycling technology, or PCT, instruments, and related products and services rose to $283,382 from $159,202 in Q2 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.